Falecalcitriol
As of the edition of 20 October 2026, Falecalcitriol is a small molecule: marketed, first approved in 2001 (JP).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2001
- Kind
- Small molecule
- First approved
- 4 April 2001 (JP)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Taisho Pharmaceutical
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Taisho Pharmaceutical | Originator | 2001 to now |